AliveCor has received an additional FDA 510(k) clearance, this time for an algorithm that allows its smartphone ECG to detect atrial fibrillation -- an abnormal heart rhythm that isn't always ...

Some 2,000 people have taken part in a ground-breaking trial to test an algorithm that can help doctors identify people at risk of developing atrial fibrillation (AF). The trial is evaluating an ...

Smartphone-enabled heart monitor device maker AliveCor has launched a new app for patients, which is both timed with the new iOS 8 launch and incorporates the atrial fibrillation algorithm the company ...

The lead-I electrocardiogram (ECG) devices were assessed when they were used in addition to 12‑lead ECGs. Clinical experts advised that a 12‑lead ECG would still be used after lead-I ECGs to identify ...

We conducted an international, open-label, randomized, blinded-outcome-assessment trial involving 1284 patients who had undergone successful catheter ablation for atrial fibrillation at least 1 year ...

Atrial fibrillation diagnosed before age 70 years is associated with a 21% increased risk of developing dementia and a 36% higher risk for early-onset forms of the condition, according to the results ...

Researchers evaluated a drug that represents a new class of anticoagulants known as Factor XI inhibitors for treating patients with atrial fibrillation as part of the AZALEA-TIMI 71 Study. The trial ...